
BioNTech
BioNTech is a Biotechnology company from Germany. It was founded in 2008 by Özlem Türeci and Uğur Şahin. Its headquarters are in Mainz. Its chief executive is Uğur Şahin. It has 1,300 employees (2019).
- Founded
- June 2008
- Founded by
- Özlem Türeci
- Headquarters
- Mainz
- Industry
- pharmaceutical industry
- Chief executive
- Uğur Şahin (2008–)
- Employees
- 1,300 (2019)
All 14 facts, and where they come from
Facts
14 facts · 0 confirmed by two sources · 8 cited · 6 from one source
Where this comes from
Papalocal keeps its own record. It started from these sources; what each one said is kept here as it was copied, so a change on their side never changes this page by itself. Tap one to read its version.
What Wikidata says · copied November 16, 2026 · revision 2534564423
- Described as
- Biotechnology company from Germany
- Other names
- Biopharmaceutical New Technologies, Biontech, BioNTech SE, BioNTech AG, BNT, BNTX, BionTech
- What it is
- business · 1 reference; enterprise; public company
- Country of origin
- Germany
- Founded
- June 2008 · 1 reference
- Founded by
- Özlem Türeci; Uğur Şahin
- Headquarters
- Mainz · 1 reference
- Country
- Germany · 3 references
- Industry
- pharmaceutical industry · 1 reference
- Chief executive
- Uğur Şahin (2008–) · 1 reference
- Employees
- 1,300 (2019) · 1 reference
- Owned by
- AT Impf (2020) · 1 reference
- Official website
- https://biontech.de/ · 1 reference
- Wikipedias with a page
- 45
Wikidata item Q30256699 (wikidata.org/wiki/Q30256699), public domain (CC0). Copied 2026-11-16.
What Wikipedia says · copied November 16, 2026 · revision 1376511113
BioNTech SE ( bee-ON-tek; or bye-ON-tek short for Biopharmaceutical New Technologies) is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes.
In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic.
From the Wikipedia article “BioNTech” (en.wikipedia.org/wiki/BioNTech), by its contributors, under CC BY-SA 4.0 (creativecommons.org/licenses/by-sa/4.0/). Copied 2026-11-16; not changed.
Confirmed Two sources agree. Cited One source, and it names where it got it. One source One source, without a reference of its own. Sources disagree The sources disagree. We show the best-supported value and keep theirs below.
Picture: Wikimedia Commons: Mainz.BioNTechSE.20200731.jpg · See Commons file page
